BTB domain and CNC homolog 2 (BACH2) (BACH2)

BACH2 is a highly conserved transcriptional repressor of the bZip family that contains a BTB (Broad complex, Tramtrack, and Bric-à-brac) domain. It acts as a master regulator of immune cell differentiation and function, especially in T and B lymphocytes. In T cells, BACH2 maintains quiescence and suppresses differentiation into effector lineages by repressing the chromatin accessibility and activity of differentiation-promoting transcription factors, such as AP-1 and IRF4. It is crucial for the generation and maintenance of stable, suppressive FOXP3^+^ regulatory T cells (Tregs), thereby preventing lethal inflammation and autoimmunity. In B cells, it is necessary for proper class-switch recombination and somatic hypermutation. Loss or dysfunction of BACH2 is implicated in human autoimmune conditions and can alter susceptibility to cancer and inflammatory diseases[1][3][5][6][7][9]. No approved drugs currently target BACH2 directly, but modulation of its activity is considered a therapeutic strategy, particularly to improve the stability and function of Treg cell therapies and modulate immune responses in autoimmune disease or cancer[7].

Other names

BTB and CNC homology 2BACH2 transcription factor

Drugs or genetic modulation of BACH2 could stabilize or destabilize regulatory T cell (Treg) lineage commitment, potentially enhancing or suppressing immune tolerance[7][5]. Modulation may impact immune cell fate decisions by altering chromatin accessibility and gene expression in Tregs and effector T cells[7][5][9]. Potential mechanisms include attenuation of AP-1 transcription factor activity and repression of effector differentiation programs[6][7].